There was a slight nonsignificant (p > 0.05) decrease of PPAR-γ in the kidney tissues of the NAFLD group in comparison to the control group (Figure 2(c)). The gene discussed is PPARG; the disease is metabolic dysfunction-associated steatotic liver disease.